Central Hemodynamics and Arterial Stiffness in Systemic Sclerosis

Hypertension

Volumn 68, Issue 6, 2016, Pages 1504-1511

  Bartoloni, Elena ^a   Pucci, Giacomo ^a,b   Cannarile, Francesca ^a   Battista, Francesca ^a,b   Alunno, Alessia ^a   Giuliani, Marco ^a,b   Cafaro, Giacomo ^a   Gerli, Roberto ^a   Schillaci, Giuseppe ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Terni University Hospital   (Italy)

Author keywords

atherosclerosis; blood pressure; C reactive protein; cardiovascular disease; prognosis

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE; AORTA AUGMENTATION; AORTOBRACHIAL PULSE PRESSURE AMPLIFICATION; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; CAROTID ARTERY; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; FEMORAL ARTERY; HEART RATE; HEMODYNAMICS; HUMAN; MEAN ARTERIAL PRESSURE; MIDDLE AGED; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RADIAL ARTERY; SYSTEMIC SCLEROSIS; TONOMETRY; AGED; ARTERIAL PRESSURE; BLOOD FLOW VELOCITY; CASE CONTROL STUDY; DISEASE COURSE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

AGE FACTORS; AGED; ARTERIAL PRESSURE; BLOOD FLOW VELOCITY; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HEMODYNAMICS; HUMANS; LINEAR MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; VASCULAR STIFFNESS;

EID: 84991434495     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08345     Document Type: Article

References (52)

1. Nicolosi PA, Tombetti E, Maugeri N, Rovere-Querini P, Brunelli S, Manfredi AA. Vascular remodelling and mesenchymal transition in systemic sclerosis. Stem Cells Int. 2016;2016:4636859. doi: 10.1155/2016/4636859.
2. Denton CP. Systemic sclerosis: from pathogenesis to targeted therapy. Clin Exp Rheumatol. 2015;33(4 suppl 92):S3-S7.
3. Liu J, Zhang Y, Cao TS, Duan YY, Yuan LJ, Yang YL, Li Y, Yao L. Preferential macrovasculopathy in systemic sclerosis detected by regional pulse wave velocity from wave intensity analysis: comparisons of local and regional arterial stiffness parameters in cases and controls. Arthritis Care Res (Hoboken). 2011;63:579-587. doi: 10.1002/acr.20306.
4. Aviña-Zubieta JA, Man A, Yurkovich M, Huang K, Sayre EC, Choi HK. Early Cardiovascular disease after the diagnosis of systemic sclerosis. Am J Med. 2016;129:324-331. doi: 10.1016/j.amjmed.2015.10.037.
5. Man A, Zhu Y, Zhang Y, Dubreuil M, Rho YH, Peloquin C, Simms RW, Choi HK. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis. 2013;72:1188-1193. doi: 10.1136/annrheumdis-2012-202007.
6. Bartoloni E, Shoenfeld Y, Gerli R. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res (Hoboken). 2011;63:178-183. doi: 10.1002/acr.20322.
7. Bartoloni E, Baldini C, Schillaci G, Quartuccio L, Priori R, Carubbi F, Bini V, Alunno A, Bombardieri S, De Vita S, Valesini G, Giacomelli R, Gerli R. Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. J Intern Med. 2015;278:185-192. doi: 10.1111/joim.12346.
8. Soriano A, Afeltra A, Shoenfeld Y. Is atherosclerosis accelerated in systemic sclerosis? Novel insights. Curr Opin Rheumatol. 2014;26:653-657. doi: 10.1097/BOR.0000000000000115.
9. Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant metaanalysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63:636-646. doi: 10.1016/j.jacc.2013.09.063.
10. Weber T, Auer J, O'rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005;26:2657-2663. doi: 10.1093/eurheartj/ehi504.
11. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865-1871. doi: 10.1093/eurheartj/ehq024.
12. Avolio AP, Van Bortel LM, Boutouyrie P, Cockcroft JR, McEniery CM, Protogerou AD, Roman MJ, Safar ME, Segers P, Smulyan H. Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension. 2009;54:375-383. doi: 10.1161/HYPERTENSIONAHA.109.134379.
13. Nilsson PM, Boutouyrie P, Laurent S. Vascular aging: A tale of EVA and ADAM in cardiovascular risk assessment and prevention. Hypertension. 2009;54:3-10. doi: 10.1161/HYPERTENSIONAHA.109.129114.
14. Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, Bertacchini F, Stassaldi D, Gavazzi A, Porteri E, De Ciuceis C, Agabiti-Rosei E. Pulsatile hemodynamics and microcirculation: evidence for a close relationship in hypertensive patients. Hypertension. 2013;61:130-136. doi: 10.1161/HYPERTENSIONAHA.111.00006.
15. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, London GM. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738. doi: 10.1161/hy0202.098325.
16. Hashimoto J, Imai Y, O'Rourke MF. Monitoring of antihypertensive therapy for reduction in left ventricular mass. Am J Hypertens. 2007;20:1229-1233. doi: 10.1016/j.amjhyper.2007.07.010.
17. Timár O, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, Szücs G. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol. 2008;35:1329-1333.
18. Cypiene A, Laucevicius A, Venalis A, Dadoniene J, Ryliskyte L, Petrulioniene Z, Kovaite M, Gintautas J. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol. 2008;27:1517-1522. doi: 10.1007/s10067-008-0958-1.
19. Roustit M, Simmons GH, Baguet JP, Carpentier P, Cracowski JL. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol. 2008;35:1576-1583.
20. Colaci M, Giuggioli D, Manfredi A, Sebastiani M, Coppi F, Rossi R, Ferri C. Aortic pulse wave velocity measurement in systemic sclerosis patients. Reumatismo. 2012;64:360-367. doi: 10.4081/reumatismo.2012.360.
21. Domsic RT, Dezfulian C, Shoushtari A, Ivanco D, Kenny E, Kwoh CK, Medsger TA Jr, Champion HC. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients. Clin Exp Rheumatol. 2014;32(6 suppl 86):S154-S160.
22. Ngian GS, Sahhar J, Wicks IP, Van Doornum S. Arterial stiffness is increased in systemic sclerosis: a cross-sectional comparison with matched controls. Clin Exp Rheumatol. 2014;32(6 suppl 86):S161-S166.
23. Irzyk K, Bienias P, Rymarczyk Z, Bartoszewicz Z, Siwicka M, Bielecki M, Karpińska A, Dudzik-Niewiadomska I, Pruszczyk P, Ciurzyński M. Assessment of systemic and pulmonary arterial remodelling in women with systemic sclerosis. Scand J Rheumatol. 2015;44:385-388. doi: 10.3109/03009742.2015.1021710.
24. Peled N, Shitrit D, Fox BD, Shlomi D, Amital A, Bendayan D, Kramer MR. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol. 2009;36:970-975. doi: 10.3899/jrheum.081088.
25. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol. 2001;28:1573-1576.
26. van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737-2747. doi: 10.1002/art.38098.
27. Mancia G, Fagard R, Narkiewicz K, et al; Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-2219. doi: 10.1093/eurheartj/eht151.
28. Valentini G, Della Rossa A, Bombardieri S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis. 2001;60:592-598. doi: 10.1136/ard.60.6.592.
29. Medsger TA Jr, Silman AJ, Steen VD, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159-2167.
30. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000;27:155-160.
31. Schillaci G, De Socio GV, Pirro M, Savarese G, Mannarino MR, Baldelli F, Stagni G, Mannarino E. Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection. Arterioscler Thromb Vasc Biol. 2005;25:2381-2385. doi: 10.1161/01.ATV.0000183744.38509.de.
32. Schillaci G, Sarchielli P, Corbelli I, Pucci G, Settimi L, Mannarino MR, Calabresi P, Mannarino E. Aortic stiffness and pulse wave reflection in young subjects with migraine: a case-control study. Neurology. 2010;75:960-966. doi: 10.1212/WNL.0b013e3181f25ecd.
33. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932-937. doi: 10.1161/hy1001.096106.
34. Menard S. Applied Logistic Regression Analysis: SAGE University Series on Quantitative Applications in the Social Sciences. Thousand Oaks, CA: SAGE Publications; 1995.
35. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007;66:940-944. doi: 10.1136/ard.2006.066068.
36. Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 2015;11:693-704. doi: 10.1038/nrrheum.2015.112.
37. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69:1809-1815. doi: 10.1136/ard.2009.114264.
38. Dave AJ, Fiorentino D, Lingala B, Krishnan E, Chung L. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014;66:323-327. doi: 10.1002/acr.22152.
39. Kavian N, Batteux F. Macro-and microvascular disease in systemic sclerosis. Vascul Pharmacol. 2015;71:16-23. doi: 10.1016/j.vph.2015.05.015.
40. Altorok N, Wang Y, Kahaleh B. Endothelial dysfunction in systemic sclerosis. Curr Opin Rheumatol. 2014;26:615-620. doi: 10.1097/BOR.0000000000000112.
41. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 2010;121:505-511. doi: 10.1161/CIRCULATIONAHA.109.886655.
42. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:1328-1336. doi: 10.1161/HYPERTENSIONAHA.109.137653.
43. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, Cockcroft JR, Wilkinson IB; Anglo-Cardiff Collaborative Trial Investigators. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008;51:1476-1482. doi: 10.1161/HYPERTENSIONAHA.107.105445.
44. Othmane Tel H, Nemcsik J, Fekete BC, Deák G, Egresits J, Fodor E, Logan AG, Németh ZK, Járai Z, Szabó T, Szathmári M, Kiss I, Tislér A. Arterial stiffness in hemodialysis: which parameter to measure to predict cardiovascular mortality? Kidney Blood Press Res. 2009;32:250-257. doi: 10.1159/000238822.
45. Bursztyn M, Norton GR, Ben-Dov IZ, Booysen HL, Sibiya MJ, Sareli P, Woodiwiss AJ. Aortic pulse pressure amplification imputed from simple clinical measures adds to the ability of brachial pressure to predict survival. Am J Hypertens. 2016;29:754-762. doi: 10.1093/ajh/hpv176.
46. Jain S, Khera R, Corrales-Medina VF, Townsend RR, Chirinos JA. "Inflammation and arterial stiffness in humans". Atherosclerosis. 2014;237:381-390. doi: 10.1016/j.atherosclerosis.2014.09.011.
47. Schillaci G, Bartoloni E, Pucci G, Pirro M, Settimi L, Alunno A, Gerli R, Mannarino E. Aortic stiffness is increased in polymyalgia rheumatica and improves after steroid treatment. Ann Rheum Dis. 2012;71:1151-1156. doi: 10.1136/annrheumdis-2011-200751.
48. Mäki-Petäjä KM, Elkhawad M, Cheriyan J, Joshi FR, Ostör AJ, Hall FC, Rudd JH, Wilkinson IB. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation. 2012;126:2473-2480. doi: 10.1161/CIRCULATIONAHA.112.120410.
49. Aïssou L, Meune C, Avouac J, Meunier M, Elhaï M, Sorbets E, Kahan A, Allanore Y. Small, medium but not large arteries are involved in digital ulcers associated with systemic sclerosis. Joint Bone Spine. 2016;83:444-447. doi: 10.1016/j.jbspin.2015.09.003.
50. Nordin A, Jensen-Urstad K, Björnadal L, Pettersson S, Larsson A, Svenungsson E. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther. 2013;15:R87. doi: 10.1186/ar4267.
51. Sacre K, Escoubet B, Pasquet B, Chauveheid MP, Zennaro MC, Tubach F, Papo T. Increased arterial stiffness in systemic lupus erythematosus (SLE) patients at low risk for cardiovascular disease: a cross-sectional controlled study. PLoS One. 2014;9:e94511. doi: 10.1371/journal.pone.0094511.
52. Boutouyrie P, Lacolley P, Briet M, Regnault V, Stanton A, Laurent S, Mahmud A. Pharmacological modulation of arterial stiffness. Drugs. 2011;71:1689-1701. doi: 10.2165/11593790-000000000-00000.